These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4991617)

  • 41. Clinical and bacteriological results with Myambutol.
    Goldman S; Brzaković N; Muzikravić T
    Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
    [No Abstract]   [Full Text] [Related]  

  • 42. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 44. [Factors affecting the activity of streptomycin, kanamycin and isoniazid in relation to intracellular Mycobacterium tuberculosis].
    Pavlov EP
    Probl Tuberk; 1970; 48(9):72-6. PubMed ID: 4996496
    [No Abstract]   [Full Text] [Related]  

  • 45. [Thiacetazone (Tb-1): recent experimental and clinical data].
    Grosset J; Benhassine M
    Bibl Tuberc; 1970; 26():107-53. PubMed ID: 4189928
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug therapy of urogenital tuberculosis].
    König K
    Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1968 Apr; 13(4):355-9. PubMed ID: 4970747
    [No Abstract]   [Full Text] [Related]  

  • 48. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
    Jesiotr M
    Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133
    [No Abstract]   [Full Text] [Related]  

  • 49. [CHANGES IN THE SENSITIVITY TO CHEMOTHERAPY OF MYCOBACTERIUM TUBERCULOSIS IN ANIMAL ORGANISMS].
    SOLOVEV VN; ZUEVA VS
    Probl Tuberk; 1964; 42():62-6. PubMed ID: 14241345
    [No Abstract]   [Full Text] [Related]  

  • 50. An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
    Hokama S
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):57-61. PubMed ID: 5317096
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract]   [Full Text] [Related]  

  • 52. Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
    Kradolfer F
    Antibiot Chemother; 1970; 16():352-60. PubMed ID: 5523730
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of kanamycin and isoniazid on the sensitivity of Mycobacterium tuberculosis to the defensive factors of the macroorganism].
    Solov'ev VN; Sokolova EM; Chumachenko NV
    Probl Tuberk; 1965; 43(10):69-72. PubMed ID: 4959763
    [No Abstract]   [Full Text] [Related]  

  • 54. Experimental studies on the combined effect of kanamycin and viomycin.
    Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):62-9. PubMed ID: 4320009
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 56. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical applications of ethambutol.
    Pyle MM
    Tubercle; 1969 Mar; 50():Suppl:30-2. PubMed ID: 4918611
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
    Suzuki T
    Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.